FABIENNE LUCAS, MD, PHD
Department of Pathology
Brigham and Women's Hospital
Harvard Medical School
Boston, Massachusetts
NICOLE TOLAN PHD, DABCC
Department of Pathology
Brigham and Women's Hospital
Harvard Medical School
Boston, Massachusetts
Primary Audience: Phlebotomists, Laboratory Technologists, Laboratory Directors
Secondary Audience: Pathologists, Clinical Scientists (Includes all sub-specialty areas), Students, Pathologist Assistants, Residents, and Students
Upon completion of this activity, you will be able to:
· interpret the Clinical and Laboratory Standards Institute’s recommended nomenclature for oxygenation parameters;
· evaluate blood oxygen content, hemoglobin states and types, and oxygen-hemoglobin dissociation curves;
· differentiate testing principles and performance characteristics of clinical laboratory assays that establish oxygenation parameters;
· recognize how oxygenation parameters correlate with each other and what their perturbation is in individuals with sickle cell disease (SCD); and
· distinguish the implications of hypoxemia/hypoxia in SCD pathophysiology and SCD-related morbidity and mortality
· discuss how the laboratory can support clinical management of oxygenation in individuals with SCD.